A limitation here is that the small number of NEPTUNE patients with 2 APOL1 risk alleles and glomerular WWC1 expression levels available (n = 16 patients) restricts any conclusion as to whether WWC1 expression levels significantly increase the risk of renal disease for patients based on APOL1 genotypes. This evidence concerns the gene WWC1 and kidney disorder.